This inventor holds 1 USPTO granted patent. Top assignee: Ivax Drug Research Institute. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: György Somogyi: An Innovative Mind in Microbial Pharmacology
Introduction
György Somogyi is a distinguished inventor based in Budapest, Hungary, known for his contribution to the field of microbial pharmacology. His innovative approach to drug development has led to a notable patent that showcases his expertise and dedication to advancing medical science through microbial processes.
Latest Patents
Somogyi holds a single patent titled "Hydroxylation of compactin pravastatin by micromonospora." This invention pertains to a novel microbial process for synthesizing compound formula (I) from a compound of general formula (II). The process involves submerged culture techniques utilizing a specific strain capable of 6β-hydroxylation in aerobic fermentation conditions. Somogyi's methodology allows for the efficient transformation of the substrate, followed by separation and purification of the desired compound, a significant advancement in bioconversion technology.
Career Highlights
György Somogyi’s professional journey has been marked by his pivotal role at the Ivax Drug Research Institute, where he has made substantial contributions to drug research and development. His work focuses on leveraging microbial systems to optimize the production of pharmaceuticals, thereby enhancing their therapeutic efficacy and safety.
Collaborations
Throughout his career, Somogyi has collaborated with impressive colleagues such as Antónia Jekkel and Gábor Ambrus. These partnerships have fostered a creative and innovative research environment, allowing them to push the boundaries of what is possible in microbial drug synthesis.
Conclusion
György Somogyi exemplifies the spirit of innovation in the pharmaceutical industry. His patent work not only reflects his individual talent but also highlights the collaborative efforts within research settings that lead to breakthroughs in drug development. As the field of microbial pharmacology continues to grow, Somogyi's contributions will remain significant in shaping future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile